Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bangladesh Leads Least Developed Country Call For IP Waiver

This article was originally published in PharmAsia News

Executive Summary

Mammoth price differentials between patented and locally produced drugs in a country where nearly 25 million people live in extreme poverty are some of the justifications emerging from Bangladesh's promising pharmaceutical industry as the country led Least Developed Country (LDCs) members of the World Trade Organization (WTO) to seek an extension of the transitional period to enforce intellectual property rights on medicines.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts